Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
暂无分享,去创建一个
L. Chin | M. Stratton | A. Protopopov | I. Perna | C. Brennan | P. Futreal | P. Campbell | S. Edkins | A. Look | B. Feng | R. DePinho | J. Aster | Kwok-Kin Wong | J. O'neil | C. Stevens | B. Choudhury | A. Gutierrez | P. A. Futreal | L. Foroni | Shan Jiang | K. McNamara | E. Martin | J. Rowe | Vidya Mani | A. Fielding | R. Wiedemeyer | A. Goldstone | Eric Lin | E. Ivanova | C. Nogueira | M. Mansour | G. Histen | Sara Zaghlul | V. Duke | O. Kabbarah | R. Maser | Y. Wang | Y. A. Wang | E. Lin | E. Martin | Peter J. Campbell | Kwok-kin Wong | Michael R. Stratton | Bhudipa Choudhury | M. Stratton | Bin Feng | Peter J. Campbell
[1] M. Kelliher,et al. The Notch1/c-Myc Pathway in T Cell Leukemia , 2007, Cell cycle.
[2] David Botstein,et al. Identification of alterations in DNA copy number in host stromal cells during tumor progression , 2006, Proceedings of the National Academy of Sciences.
[3] L. Chin,et al. Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene , 2006, Cell.
[4] M. Wigler,et al. Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach , 2006, Cell.
[5] Ralph Weissleder,et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] G. Tseng,et al. Comparison of gene expression and DNA copy number changes in a murine model of lung cancer , 2006, Genes, chromosomes & cancer.
[7] L. Chin,et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. , 2006, Cancer cell.
[8] L. Foroni,et al. High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia , 2006, Leukemia.
[9] F. Alt,et al. Activating Notch1 mutations in mouse models of T-ALL. , 2005, Blood.
[10] O. Sieber,et al. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. , 2005, Cancer research.
[11] D. Hanahan,et al. Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis , 2005, Oncogene.
[12] B. Clurman,et al. Mechanisms of Tumor Suppression by the SCFFbw7 , 2005, Cell cycle.
[13] Andrew D. Yates,et al. Somatic mutations of the protein kinase gene family in human lung cancer. , 2005, Cancer research.
[14] L. Chin,et al. High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Haber,et al. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer. , 2005, Gynecologic oncology.
[16] Margaret A. Strong,et al. Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation , 2005, Nature Cell Biology.
[17] D. Pinkel,et al. Array comparative genomic hybridization and its applications in cancer , 2005, Nature Genetics.
[18] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[19] J. Mesirov,et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis , 2005, Nature Genetics.
[20] L. Strong,et al. Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome , 2004, Cell.
[21] T. Jacks,et al. Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.
[22] Allan Balmain,et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene , 2004, Nature.
[23] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[24] A. Ferrando,et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.
[25] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[26] L. Pan,et al. Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias. , 2004, Cancer letters.
[27] William R Sellers,et al. The biology and clinical relevance of the PTEN tumor suppressor pathway. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Andrew D. Hamilton,et al. Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt , 2004, Cancer Research.
[29] L. Chin,et al. High-resolution characterization of the pancreatic adenocarcinoma genome , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] Carlo Rago,et al. Inactivation of hCDC4 can cause chromosomal instability , 2004, Nature.
[31] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[32] Freddy Radtke,et al. Notch regulation of lymphocyte development and function , 2004, Nature Immunology.
[33] Margaret A. Strong,et al. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. , 2003, Cancer research.
[34] Wing Hung Wong,et al. Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma. , 2003, Cancer research.
[35] Robert M. Bachoo,et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing , 2003, Nature.
[36] M. Tyers,et al. Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCFCdc4 Ubiquitin Ligase , 2003, Cell.
[37] L. Chin,et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. , 2002, Cancer cell.
[38] F. Alt,et al. Unrepaired DNA Breaks in p53-Deficient Cells Lead to Oncogenic Gene Amplification Subsequent to Translocations , 2002, Cell.
[39] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[40] R. DePinho,et al. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans , 2001, Nature Genetics.
[41] Y. Shiloh,et al. ATM: genome stability, neuronal development, and cancer cross paths. , 2001, Advances in cancer research.
[42] D. Hanahan,et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas , 2001, Nature Genetics.
[43] T. Ried,et al. Abnormal rearrangement within the α/δ T-cell receptor locus in lymphomas from Atm-deficient mice , 2000 .
[44] Lynda Chin,et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice , 2000, Nature.
[45] Lynda Chin,et al. E.: “A Summary of , 1968 .
[46] T. Mak,et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.
[47] Raphael Kopan,et al. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.
[48] K. Georgopoulos,et al. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma , 1995, Cell.
[49] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[50] G. Wahl,et al. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. , 1991, Genes & development.